CHINWAGYThe world's live brand collaboration wire
Join freeCreatorsIndustryContact
For you +
ReadersCreatorsBrands & IndustryContact Chinwagy

THE CHINWAGY BUZZ · FIRST VERIFIED WORD

AstraZeneca and Summit Therapeutics enter clinical collaboration to advance ADC combination strategy

AstraZeneca×Summit Therapeutics

WHAT CHINWAGY KNOWS

The collaboration
is confirmed.

AstraZeneca and Summit Therapeutics entered a clinical collaboration to evaluate AstraZeneca’s sonesitatug vedotin in combination with Summit’s ivonescimab in gastrointestinal cancers. The companies will contribute their respective medicines and jointly contribute to trial costs, with a broader development programme also contemplated.

Current status
Official collaboration
Known availability
The published source describes the collaboration; timing details remain under review.
Place
International, Global
Source checked
September 29, 2026

SHARE OR FOLLOW THE BUZZ

Keep it moving.

Share the permanent Chinwagy profile, download a branded social card or save the story so its next update stays within reach.

FOLLOW THE STORY

More details will move this intelligence into the right Chinwagy destination.